PODCAST

OB/GYN and Women"s Health

ReachMD

science & medicine medicine

All Episodes

00:00:00

Overcoming Bias and Stigma in Endometriosis:...

OB/GYN and Women"s Health ·

2025/07/24

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Whitney Trotter Ross, MD, MSCI Despite advances in endometriosis treatment, bias and stigma continue to delay diagnosis and disrupt care for many patients. Informed, empathetic care is key for supporting diverse patient populations. Dr. Charles Turck sits down with Dr. Whitney Ross to unpack how historical misconceptions still influence prescribing habits and discuss actionable strategies for counseling, selecting a treatment plan,

00:00:00

New 3D MRI Technology Offers Enhanced Visibility...

OB/GYN and Women"s Health ·

2025/07/21

Guest: Tamatha Fenster, M.D., M.S. Tamatha Fenster, M.D., M.S., gynecologic surgeon at NewYork-Presbyterian and director of innovation and technology at The Weill Cornell Medicine Fibroid and Adenomyosis Center, explains how her team has developed a new 3D MRI technology to enhance patient outcomes in fibroid surgery. The novel software, called smartHER MRI, renders a 3D image of a patient’s uterus to more accurately identify fibroids and their precise location, which can be used for

00:00:00

The Burden of Uterine Fibroids: Exploring Physical,...

OB/GYN and Women"s Health ·

2025/06/04

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP In addition to heavy menstrual bleeding, patients with uterine fibroids often deal with many other considerable effects on their physical and mental wellbeing. To provide optimal care, it’s important to recognize the full impact of fibroids, communicate carefully about treatment options, and promote equitable access to care. Dr. Charles Turck sits down with Dr. Ayman Al-Hendy to learn more

00:00:00

A Whole-Patient Approach to Endometriosis: Closing...

OB/GYN and Women"s Health ·

2025/06/04

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Joseph E. Patruno, MD From delayed diagnosis to chronic pain and fertility issues, endometriosis presents a range of challenges that require individualized attention. By focusing on each patient’s unique symptoms and priorities, we can better tailor care and improve outcomes. Join Dr. Mary Katherine Cheeley as she speaks with Dr. Joseph Patruno, an OB/GYN at Lehigh Valley Jefferson Health Network, about practical

00:00:00

Importance of a Timely Postpartum Depression...

OB/GYN and Women"s Health ·

2024/07/08

Host: Matt Birnholz, MD Guest: Kay Matthews, LCHW Ms. Kay Matthews has lived experience with postpartum depression and now advocates for others as the Executive Director and Founder of Shades of Blue, which is dedicated to breaking cultural barriers in maternal mental health. Tune in to hear her speak with Dr. Matt Birnholz about her journey with postpartum depression, barriers that can prevent or delay patients from seeking care, and strategies for combatting stigma and ensuring a

00:00:00

EMERALD Trial: An Analysis of Key Biomarkers and...

OB/GYN and Women"s Health ·

2024/05/31

Host: Jennifer Caudle, DO Guest: Joyce O'Shaughnessy, MD The results from the phase III EMERALD trial led to the approval of ORSERDU® (elacestrant) as the first oral selective estrogen receptor degrader for ER-positive/HER2-negative metastatic breast cancer patients with ESR1 mutations after disease progression following at least one line of endocrine therapy.1 But given the results from prior analyses, clinicians wanted to better understand the data for elacestrant in

00:00:00

Delivering Transformation: Reducing Maternal...

OB/GYN and Women"s Health ·

2024/04/16

Guest: Dena Goffman, MD Dr. Dena Goffman believes that better maternal care requires a proactive, system-wide approach and is making her vision a reality at NewYork-Presbyterian. She focuses on implementing guidelines that standardize care across all of NewYork-Presbyterian’s hospitals. Dr. Goffman has also aided in FDA approval and adoption of a new, ingenious hemorrhage tool and embraced simulations to train and improve the skills of healthcare professionals throughout the labor and

00:00:00

The Dynamic Practice: Exploring Locum Tenens...

OB/GYN and Women"s Health ·

2024/04/03

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Derrick Barnes, MD “Whatever dream you have of what you want your practice to look like, you can do.” That’s what OB-GYN Dr. Derrick Barnes believes when it comes to beginning a career in locum tenens. Tune in to hear Dr. Barnes share his experience with locum tenens work and how it offered him variety and flexibility in his career.

00:00:00

Active Aging: Preventing Heart Failure in Older Women...

OB/GYN and Women"s Health ·

2024/03/19

Host: Javed Butler, MD, MBA, MPH Guest: Michael J. LaMonte, PhD, MPH The American Heart Association recommends physical activity to help lower the risk of heart failure, but how much exercise is needed, especially for older women, to lower that risk? According to a recent study, even just low-intensity exercise for 30 minutes is associated with a 25 percent lower risk of overall heart failure. Dive further into the findings with Dr. Javed Bulter and Dr. Michael LaMonte, a Research

00:00:00

Disparities in DMT Access: Women with MS Are Less...

OB/GYN and Women"s Health ·

2024/03/18

Host: Andrew Wilner, MD, FACP, FAAN Guest: Victoria Leavitt, PhD Disease-modifying therapies (DMTs) are an effective option for patients with multiple sclerosis (MS). In fact, a recent study presented at the 2023 joint ECTRIMS-ACTRIMS meeting in Italy found that MS patients being treated with a DMT had better cognitive function than those who were not. However, the same study also found that women are less likely than men to receive DMT treatment. Dive further into the findings

00:00:00

Family Planning Clinical Considerations for Patients...

OB/GYN and Women"s Health ·

2024/03/04

Host: Ashley Baker, MSN, PMHNP Guest: Anna Shah, MD The prevalence of multiple sclerosis seems to be increasing in patients, and the majority of those patients are diagnosed with MS around the peak family planning age. So family planning should be an integral part of comprehensive patient-centered MS care. Learn more with Psychiatric Nurse Practitioner Ashey Baker as she speaks with Dr. Anna Shah, Assistant Professor of Neurology and the Director of Neurology Outpatient Patient

00:00:00

Ovarian Cancer: Advances in HER2-Targeted ADCs

OB/GYN and Women"s Health ·

2024/01/17

Guest: Kathleen Moore, MD, MS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.

00:00:00

Cervical Cancer: HER2-Targeted ADCs – Current Status...

OB/GYN and Women"s Health ·

2024/01/17

00:00:00

Management Strategies for Treatment-Emergent Adverse...

OB/GYN and Women"s Health ·

2024/01/17

Host: Kathleen Moore, MD, MS Guest: Brad McGregor, MD HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.

00:00:00

Addressing the Unmet Need in HER2-Positive Advanced...

OB/GYN and Women"s Health ·

2024/01/17

Guest: Susana Banerjee, MBBS, MA, FRCP, PhDHER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.

00:00:00

Biliary Tract and Pancreatic Cancer: HER2-Targeted...

OB/GYN and Women"s Health ·

2024/01/17

Guest: Shubham Pant, MD, MBBS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.

00:00:00

Testing for Solid Tumors: Tissue and Liquid Biopsy...

OB/GYN and Women"s Health ·

2024/01/17

00:00:00

Targeting HER2 in Advanced Solid Tumors: A...

OB/GYN and Women"s Health ·

2024/01/17

00:00:00

Endometrial Cancer: HER2-Targeted ADCs: A Promising...

OB/GYN and Women"s Health ·

2024/01/17

00:00:00

ASCO/ESMO 2023 Roundtable: Contextualizing the Latest...

OB/GYN and Women"s Health ·

2024/01/17

Host: Kathleen Moore, MD, MS Guest: Susana Banerjee, MBBS, MA, FRCP, PhD Guest: Shubham Pant, MD, MBBS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and

382 results

OB/GYN and Women"s Health

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe